RA Capital Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
RA Capital Management's SANA Position: Q3 2026 in Review
RA Capital Management held its Sana Biotechnology (SANA) position steady in Q3 2026 at 18,750,000 shares worth $54.7M. The position accounts for 0.55% of the portfolio, ranked #33.
RA Capital Management first reported a position in SANA in Q2 2026 and has held it in 2 quarters since. The position peaked at $65.4M in Q2 2026. 203 funds tracked by Wall St. Rank hold SANA as of Q3 2026.
- RA Capital Management held 18,750,000 shares of Sana Biotechnology worth $54.7M as of Q3 2026.
- RA Capital Management left its Sana Biotechnology share count unchanged in Q3 2026.
- Sana Biotechnology made up 0.55% of RA Capital Management's portfolio in Q3 2026, its #33 holding.
- RA Capital Management first reported a position in Sana Biotechnology in Q2 2026 and has held it in 2 quarters since.
- RA Capital Management's Sana Biotechnology position peaked at $65.4M in Q2 2026.
- 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.